𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Incidence and Risk Factors for Steatosis Progression in Adults Coinfected With HIV and Hepatitis C Virus

✍ Scribed by Tinsay A. Woreta; Catherine G. Sutcliffe; Shruti H. Mehta; Todd T. Brown; Yvonne Higgins; David L. Thomas; Michael S. Torbenson; Richard D. Moore; Mark S. Sulkowski


Book ID
119761807
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
516 KB
Volume
140
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Hepatic steatosis in patients coinfected
✍ Mariana Verdelho Machado; AntΓ³nio Gouveia Oliveira; Helena Cortez-Pinto πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 262 KB πŸ‘ 1 views

Hepatic steatosis (HS) is frequent in patients with hepatitis C virus (HCV) infection, occurring in 40%-80%, associating with metabolic and virus-related factors, namely, genotype 3 and viral load. Human immunodeficiency virus (HIV) infection and antiretroviral treatment seem to be risk factors for

Hepatic steatosis in HIV/hepatitis C coi
✍ Alexander Monto; Lorna M. Dove; Alan Bostrom; Sanjay Kakar; Phyllis C. Tien; Ter πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 117 KB

Liver disease in patients coinfected with HIV and hepatitis C virus (HCV) has received increasing attention in recent years. Steatosis is accepted as an important contributor to liver disease in patients with HCV, but despite coinfected patients having several reasons to have steatosis, the prevalen